rss
Br J Ophthalmol 2004;88:843-844 doi:10.1136/bjo.2003.033589
  • Letter

Pseudohypopyon after intravitreal triamcinolone injection for the treatment of pseudophakic cystoid macular oedema

  1. S D M Chen,
  2. J Lochhead,
  3. B McDonald,
  4. C K Patel
  1. Oxford Eye Hospital, Oxford, UK
  1. Correspondence to: S Chen Oxford Eye Hospital, Woodstock rd, Oxford OX2 6HE, UK; s-chenrocketmail.com
  • Accepted 4 November 2003

Intravitreal triamcinolone injection is a safe and effective treatment for cystoid macular oedema (CMO) caused by uveitis,1 diabetic maculopathy,2 central retinal vein occlusion,3 and pseudophakic CMO.4 Potential risks include glaucoma, cataract, retinal detachment, and endophthalmitis.

We present a case of pseudohypopyon and sterile endophthalmitis following intravitreal triamcinolone injection for the treatment of pseudophakic CMO.

Case report

An 88 year old woman underwent phacoemulsification surgery which was complicated by posterior capsule rupture. Anterior vitrectomy with implantation of a silicone intraocular lens into the sulcus was performed. Postoperatively, CMO developed. This failed to respond to treatment with topical dexamethasone, topical ketorolac, and posterior sub-Tenon triamcinolone injection, limiting visual acuity to 6/24 at 7 months following the cataract surgery.

An intravitreal injection of triamcinolone acetonide (4 …

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.